Indication
Unspecified
40 clinical trials
53 products
2 drugs
Product
177Lu-LNC1004 InjectionClinical trial
Phase I, Open-Label Study of the Safety and Dosimetry of a 4-Dose Regimen of Escalating Doses of 177Lu-LNC1004 Injection in Adult Patients With Advanced Fibroblast Activation Protein (FAP)-Positive Solid TumorsStatus: Recruiting, Estimated PCD: 2025-03-10
Product
177Lu-LNC1004Product
LNC1004Clinical trial
An Open-Label, Phase 1b/2 Study to Evaluate the Safety and Efficacy of Fruquintinib in Combination With Tislelizumab in Patients With Advanced Solid TumorsStatus: Active (not recruiting), Estimated PCD: 2024-07-01
Product
FruquintinibProduct
TislelizumabProduct
Single ArmClinical trial
First in Human Safety of [68Ga]-NOTA-hGZP- PET Imaging in Subjects Receiving Checkpoint Inhibitor ImmunotherapyStatus: Recruiting, Estimated PCD: 2025-12-30
Product
MCLA-128Clinical trial
Treatment Plan of the HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid TumorStatus:
Product
DomvanalimabProduct
ZimberelimabClinical trial
A Phase 1 Study to Evaluate the Safety and Tolerability of AB154 Monotherapy and Combination Therapy in Participants With Advanced MalignanciesStatus: Active (not recruiting), Estimated PCD: 2024-11-01
Clinical trial
An Exploratory Clinical Study to Investigate the Effect of autoSTEM-OA and alloSTEM-OA in Participants With Knee Osteoarthritis.Status: Not yet recruiting, Estimated PCD: 2024-11-01
Product
FenretinideProduct
R-2487Clinical trial
Effect of Refnot on Immunity in Cancer PatientsStatus: Completed, Estimated PCD: 2011-11-01
Product
etrasimodClinical trial
A PHASE 2/3, TWO-PART STUDY TO EVALUATE THE EFFICACY AND LONG-TERM SAFETY WITH ORAL ETRASIMOD, 2 MG, ONCE DAILY IN ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS WITH A HISTORY OF PRIOR SYSTEMIC TREATMENT FAILUREStatus: Active (not recruiting), Estimated PCD: 2024-04-23
Product
PlaceboProduct
avapritinibClinical trial
A Phase 1/2, Single-arm Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA SignalingStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Phase 1, Open Label, Dose Escalation and Expansion Study of RLY-1971, a Highly Potent and Selective SHP2 Inhibitor, in Subjects With Advanced or Metastatic Solid TumorsStatus: Completed, Estimated PCD: 2022-11-22
Product
RLY-1971Product
3M CHG/IPA PrepClinical trial
Evaluation of Microbial Population Reductions Within a Defined Product Coverage AreaStatus: Completed, Estimated PCD: 2017-07-04
Product
INV-1120Product
PembrolizumabClinical trial
A Phase 1a/1b, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Evidence of Antitumor Activity of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2023-07-31
Clinical trial
The Impact of Remimazolam and Propofol on the Left Ventricular Systolic Performance During Anesthesia-induction for Non-cardiac Surgery: a Speckle Tracking Analysis of the Left Ventricular Strain Using Transthoracic EchocardiographyStatus: Recruiting, Estimated PCD: 2024-01-01
Product
RemimazolamProduct
PropofolClinical trial
Hyperlactacidemia in Major Abdominal Surgery: Role of Variation in the Monocarboxylate ReceptorsStatus: Not yet recruiting, Estimated PCD: 2025-08-01
Clinical trial
A Prospective Study on the Comparison of Postoperative Pain According to the Use of Cocktail Therapy in LaminoplastyStatus: Not yet recruiting, Estimated PCD: 2024-10-24
Product
CocktailClinical trial
Hyperbaric Oxygen for Treatment of Long COVID Syndrome; A Randomized, Placebo-Controlled, Double-Blind, Phase II Clinical TrialStatus: Active (not recruiting), Estimated PCD: 2023-09-27
Product
Hyperbaric oxygenClinical trial
Estradiol Effects on Behavioral and Reward Sensitivity to Alcohol Across the Menstrual CycleStatus: Recruiting, Estimated PCD: 2025-01-01
Product
AlcoholClinical trial
Effects of Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant OutcomesStatus: Recruiting, Estimated PCD: 2024-12-30
Product
BuprenorphineClinical trial
PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in NorwayStatus: Recruiting, Estimated PCD: 2024-04-01
Clinical trial
Opioid Modulation and Neural Reward Activation in Healthy AdultsStatus: Completed, Estimated PCD: 2022-04-18
Product
NaltrexoneClinical trial
Advancing New Computer-based Health Outreach Regarding Sexual Behavior (ANCHORS) Study: UH3 ProjectStatus: Recruiting, Estimated PCD: 2024-08-31
Product
PrEPClinical trial
Humanized CAR19T2 T Cell in Children With Refractory/Relapsed B-cell Leukemia/LymphomaStatus: Withdrawn, Estimated PCD: 2025-12-01
Product
CD19 CAR T-CellClinical trial
A Prospective Comparison of Pain and Analgesia in Patients With Continuous Peripheral Nerve Block Catheters Using Continuous Infusion or Scheduled Bolus InfusionStatus: Completed, Estimated PCD: 2024-01-16
Product
RopivacaineClinical trial
Evaluation of Opioids and Metabolites in Hair and Sweat of Pediatric Patients in a Monitored Clinical Context, by Means of Targeted Liquid Chromatography-tandem Mass SpectrometryStatus: Recruiting, Estimated PCD: 2024-12-01
Product
FentanylClinical trial
A Phase I Study of Obinutuzumab, Venetoclax, and Lenalidomide in Relapsed and Refractory B-cell Non-Hodgkin LymphomaStatus: Active (not recruiting), Estimated PCD: 2024-12-31
Product
LenalidomideProduct
ObinutuzumabProduct
VenetoclaxClinical trial
Efficacy of Ondansetron Oral Soluble Film Combined With Dexamethasone Versus Ondansetron Intravenously Combined With Dexamethasone in Prophylaxis of Chemotherapy-induced Nausea and Vomiting in Pediatric Patients : A Multi-center, Randomized, Parallel Controlled, Non-inferior Clinical Study.Status: Recruiting, Estimated PCD: 2026-07-01
Product
OndansetronClinical trial
Evaluation of the Stress Response in Bariatric Surgery With and Without the Use of OpioidsStatus: Recruiting, Estimated PCD: 2025-02-28
Product
Opioid Free AnaesthesiaProduct
Opioid based anesthesiaClinical trial
A Randomized Controlled Trial Comparing Virtual Reality Games Versus Nitrous Oxide for Pain Reduction in Common Outpatient Procedures in Pediatric SurgeryStatus: Recruiting, Estimated PCD: 2024-10-01
Product
Nitrous oxideClinical trial
Pecto-Intercostal Fascial Plane Block for Enhanced Recovery After Cardiac SurgeryStatus: Completed, Estimated PCD: 2023-09-03
Product
BupivacaineProduct
Liposomal bupivacaineClinical trial
Evaluating the Effectiveness of Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Post-Acute Sequelae of SARS-CoV-2 (PASC)Status: Active (not recruiting), Estimated PCD: 2023-06-15
Product
Stellate Ganglion BlockClinical trial
An Interventional, Double-Blinded, 2-Arm Study to Investigate the Efficacy of Orally Administered Nirmatrelvir/Ritonavir Compared With Placebo/Ritonavir in Non-hospitalized Adult Participants Suffering From Post-COVIDStatus: Recruiting, Estimated PCD: 2024-01-31
Product
Placebo/ritonavirClinical trial
Efficacy of Ulipristalacetate in Comparison to Surgery Before IVF/ICSI-treatment in Women With Intramural Fibroids: Effect on Reproductive Outcome.Status: Active (not recruiting), Estimated PCD: 2025-12-31
Product
Ulipristal AcetateClinical trial
Pectoral Nerve Blocks (PECs) for Cardiovascular Implantable Electronic Device Placement: A Pilot StudyStatus: Active (not recruiting), Estimated PCD: 2024-06-01
Clinical trial
The Effect of an Opioid-free Anesthetic on Post-operative Opioid Consumption After Laparoscopic Bariatric Surgery: a Prospective, Single-blinded, Randomized Controlled TrialStatus: Active (not recruiting), Estimated PCD: 2023-03-29
Product
Opioid AnestheticsProduct
Non Opioid AnalgesicsClinical trial
Contrast Enhanced Ultrasound and Elastography of the Neonatal BrainStatus: Not yet recruiting, Estimated PCD: 2029-07-01
Product
Sulfur HexafluorideClinical trial
Using Dronabinol to Enhance the Analgesic Effect of Hydromorphone in HumansStatus: Completed, Estimated PCD: 2020-03-23
Product
Blinded Study MedicationClinical trial
Bilateral Orthotopic Lung Transplant in Tandem With CD3+ and CD19+ Cell Depleted Bone Marrow Transplant From Partially HLA-Matched Cadaveric DonorsStatus: , Estimated PCD: 2025-11-01
Clinical trial
Influence of Craving Manipulation on Cocaine Self-AdministrationStatus: Terminated, Estimated PCD: 2021-12-03
Product
CocaineDrug
VarlilumabClinical trial
Impact of Anti-cytomegalovirus (Valganciclovir) Treatment in the Management of Relapsing Ulcerative Colitis (UC) Requiring Vedolizumab Therapy: a Randomized Clinical Trial Comparing a Strategy With or Without Antiviral Therapy.Status: Terminated, Estimated PCD: 2023-11-23
Product
ValganciclovirClinical trial
A Phase II/III, Randomised, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) for Induction and Maintenance Therapy in Patients With Mild to Moderately Active Ulcerative ColitisStatus: Not yet recruiting, Estimated PCD: 2027-08-01
Product
Low-Dose CICR-NAMProduct
High-Dose CICR-NAMProduct
CICR-NAMProduct
Open-Label